Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 17;12(1):13941.
doi: 10.1038/s41598-022-18054-6.

Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance

Affiliations

Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance

Arthur Gustavo Fernandes et al. Sci Rep. .

Abstract

The current study aimed to investigate diabetic retinopathy (DR) screening and treatment coverages among diabetic patients evaluated through the Brazilian National Health Insurance from 2014 to 2019. The Brazilian Public Health System Information Database was used as the primary data source. DR screening coverage was calculated as the rate of procedures of clinical dilated fundus exam and color fundus photograph over the number of diabetic patients. DR treatment coverage was calculated as the rate of procedures of intravitreal injection, photocoagulation, and panretinal photocoagulation over the number of diabetic patients presumably in need of DR treatment. The overall screening coverage increased from 12.1% in 2014 to 21.2% in 2019 (p < 0.001) with substantial regional discrepancies so that North region was the only one with no changes along the period. The overall treatment coverage increased from 27.7% in 2014 to 44.1% in 2019, with Southeast and Midwest absorbing the demand for service from the North, Northeast and South. Despite an improvement along the past years, both screening and treatment coverages for DR in diabetes patients are ineffective in Brazil. Public health policies should address resources disparities throughout the country aiming to offer same healthcare conditions to patients regardless their geographic location.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Diabetic retinopathy screening coverage among diabetic patients through SUS from 2014 to 2019.
Figure 2
Figure 2
Diabetic Retinopathy Screening Coverage among Diabetic Patients through SUS in 2019, by state. Source: Go-cart.io.
Figure 3
Figure 3
Diabetic Retinopathy Treatment Coverage among Diabetic Patients through SUS in 2014 and 2019, by state. Source: Go-cart.io.

Similar articles

Cited by

References

    1. Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. American Diabetes Association Classification and diagnosis of diabetes: Standards of medical care in Diabetes-2021. Diabetes Care. 2021;44:S15–S33. doi: 10.2337/dc21-S002. - DOI - PubMed
    1. Lovic D, et al. The growing epidemic of diabetes mellitus. Curr. Vasc. Pharmacol. 2020;18:104–109. doi: 10.2174/1570161117666190405165911. - DOI - PubMed
    1. Khalil H. Diabetes microvascular complications - A clinical update. Diabetes Metab. Syndr. 2017;11:S133–S139. doi: 10.1016/j.dsx.2016.12.022. - DOI - PubMed
    1. GBD Blindness and Vision Impairment Collaborators. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob. Health. 2019;9:e144–e160. - PMC - PubMed